NCT01332435View on ClinicalTrials.gov

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

CompletedOBSERVATIONAL

Enrollment

6,896

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Prostatic Hyperplasia

Interventions

DRUG

5ARI + AB

5ARI: Dutasteride or Finasteride AB: Doxazosin, Tamsulosin, Terazosin, or Alfuzosin

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01332435 - Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use | Biotech Hunter | Biotech Hunter